Xeris Biopharma Inc. (XERS)
NASDAQ: XERS
· Real-Time Price · USD
7.48
0.18 (2.47%)
At close: Aug 15, 2025, 1:30 PM
Xeris Biopharma Fail-to-Deliver
Total FTD Shares
41
Below Average
FTD / Avg. Volume
< 0.01%
Low Impact
1-Year Change
-95.3%
Negative Trend
FTD Chart
As of Jun 30, 2025,
Xeris Biopharma Inc. has
41
shares failed to deliver, representing 0.00%
of the average daily volume of
2,439,501
shares. Over the past year, the monthly average FTD is
11,590
shares, with the current level 100% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jun 30, 2025 | 4.67 | 41 | -99.70% |
| May 30, 2025 | 4.94 | 13.86K | +2290.00% |
| Apr 30, 2025 | 4.57 | 580 | -97.34% |
| Mar 31, 2025 | 5.49 | 21.84K | +1078.47% |
| Feb 20, 2025 | 3.97 | 1.85K | -2.47% |
| Jan 30, 2025 | 3.66 | 1.9K | +90.00% |
| Dec 26, 2024 | 3.5 | 1K | +900.00% |
| Nov 22, 2024 | 3.09 | 100 | -99.05% |
| Oct 29, 2024 | 3.23 | 10.55K | +786.64% |
| Sep 30, 2024 | 2.85 | 1.19K | +19.00% |
| Aug 19, 2024 | 2.72 | 1K | +45.35% |
| Jul 29, 2024 | 2.52 | 688 | -20.83% |
| Jun 21, 2024 | 2.11 | 869 | -88.40% |
| May 29, 2024 | 1.93 | 7.49K | +60.03% |
| Apr 30, 2024 | 1.75 | 4.68K | +831.01% |
| Mar 28, 2024 | 2.21 | 503 | -96.94% |
| Feb 29, 2024 | 3.08 | 16.45K | +4263.13% |
| Jan 30, 2024 | 2.52 | 377 | -91.18% |
| Dec 27, 2023 | 2.28 | 4.28K | +118.95% |
| Nov 28, 2023 | 1.79 | 1.95K | +5644.12% |
| Oct 31, 2023 | 1.83 | 34 | -88.67% |
| Sep 28, 2023 | 1.88 | 300 | -91.88% |
| Aug 14, 2023 | 2.25 | 3.69K | +593.25% |
| Jul 25, 2023 | 2.41 | 533 | +869.09% |
| Jun 28, 2023 | 2.64 | 55 | -98.11% |
| May 22, 2023 | 2.95 | 2.91K | +137.99% |
| Apr 28, 2023 | 2.26 | 1.22K | -91.28% |
| Mar 30, 2023 | 1.46 | 14.03K | +82.78% |
| Feb 28, 2023 | 1.38 | 7.68K | -77.10% |
| Jan 30, 2023 | 1.22 | 33.52K | n/a |